Hyperrab 300 unit/ML vial 5ML
Ended Awarded
- Contract number
- SPE2DB25FKE58
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,979
Award facts
- Contract value 100% obligated
- $42,979.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,979.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Hyperrab 300 Unit/mL vials (5mL units). The contract, which carries an ultimate completion date of October 21, 2025, represents a non-competitive, non-set-aside award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Hyperrab is a rabies immune globulin product used for post-exposure prophylaxis in rabies prevention protocols, making this procurement essential for medical readiness and emergency response capabilities within the Defense Health Agency and other government healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill complex pharmaceutical supply requirements across multiple therapeutic domains through the DLA's Medical Supply Chain. The company's involvement in the upcoming Pharmaceutical Prime Vendor Global Program Generation V contracts underscores its strategic importance to the Department of Defense's medical supply infrastructure.
Quick answers
Who was awarded contract SPE2DB25FKE58?
SPE2DB25FKE58 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE58 worth?
The government has obligated $42,979 on SPE2DB25FKE58.
Is contract SPE2DB25FKE58 an order under another contract?
Yes. SPE2DB25FKE58 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE58 competed?
The extent of competition for SPE2DB25FKE58 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award